CTLs are targeted to kill β cells in patients with type 1 diabetes through recognition of a glucose-regulated preproinsulin epitope

Ähnliche Einträge

• CTLs are targeted to kill β cells in patients with type 1 diabetes through recognition of a glucose-regulated preproinsulin epitope
  von: Skowera, Ania, et al.
  Veröffentlicht: (2008)
• Identification of a Naturally Processed Cytotoxic CD8 T-Cell Epitope of Coxsackievirus B4, Presented by HLA-A2.1 and Located in the PEVKEK Region of the P2C Nonstructural Protein
  von: Varela-Calvino, Ruben, et al.
  Veröffentlicht: (2004)
• Human β-Cell Killing by Autoreactive Preproinsulin-Specific CD8 T Cells Is Predominantly Granule-Mediated With the Potency Dependent Upon T-Cell Receptor Avidity
  von: Knight, Robin R., et al.
  Veröffentlicht: (2013)
• Naturally Arising Human CD4 T-Cells That Recognize Islet Autoantigens and Secrete Interleukin-10 Regulate Proinflammatory T-Cell Responses via Linked Suppression
  von: Tree, Timothy I.M., et al.
  Veröffentlicht: (2010)
• Circulating Preproinsulin Signal Peptide–Specific CD8 T Cells Restricted by the Susceptibility Molecule HLA-A24 Are Expanded at Onset of Type 1 Diabetes and Kill β-Cells
  von: Kronenberg, Deborah, et al.
  Veröffentlicht: (2012)